Bradykinin in health and disease: Proceedings of the Bradykinin Symposium 2012, Berlin 23-24 August 2012

Inflammation Research

Volumn 63, Issue 3, 2014, Pages 173-178

  Magerl, Markus ^a   Bader, Michael ^a   Gompel, Anne ^b   Joseph, Kusumam ^c   Kaplan, Allen P ^c   Kojda, Georg ^d   Renné, Thomas ^e,f   Wirth, Markus ^g   Maurer, Marcus ^a   Church, Martin K ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^e KAROLINSKA INSTITUTE   (Sweden)

^f UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^g TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOEDEMAS, HEREDITARY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BRADYKININ; DISEASE; ENDOTHELIUM; ESTROGENS; FACTOR XII; HEALTH; HUMANS; NITRIC OXIDE; RECEPTORS, BRADYKININ;

EID: 84894412583     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-013-0693-1     Document Type: Conference Paper

References (36)

1. Joseph K, Tholanikunnel BG, Kaplan AP. Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor. J Allergy Clin Immunol. 2009;124(1):143-9.
2. Polosa R, Holgate ST. Comparative airway response to inhaled bradykinin, kallidin, and [des-Arg9] bradykinin in normal and asthmatic subjects. Am Rev Respir Dis. 1990;142(6 Pt 1):1367-71.
3. Polosa R, Rajakulasingam K, Prosperini G, Milazzo LV, Santonocito G, Holgate ST. Cross-tachyphylactic airway response to inhaled bradykinin, kallidin and [desArg9]-bradykinin in asthmatic subjects. Eur Respir J. 1993;6(5):687-93.
4. Polosa R, Phillips GD, Lai CK, Holgate ST. Contribution of histamine and prostanoids to bronchoconstriction provoked by inhaled bradykinin in atopic asthma. Allergy. 1990;45(3):174-82.
5. Willis EF, Clough GF, Church MK. Investigation into the mechanisms by which nedocromil sodium, frusemide and bumetanide inhibit the histamine-induced itch and flare response in human skin in vivo. Clin Exp Allergy. 2004;34(3):450-5.
6. Rajakulasingam K, Polosa R, Lau LC, Church MK, Holgate ST, Howarth PH. Comparative nasal effects of bradykinin and histamine: influence on nasal airways resistance and plasma protein exudation. Thorax. 1993;48(4):324-9.
7. Austin CE, Foreman JC. Acoustic rhinometry compared with posterior rhinomanometry in the measurement of histamine- and bradykinin-induced changes in nasal airway patency. Br J Clin Pharmacol. 1994;37(1):33-7.
8. Clough GF, Bennett AR, Church MK. Effects of H1 antagonists on the cutaneous vascular response to histamine and bradykinin: a study using scanning laser Doppler imaging. Br J Dermatol. 1998;138(5):806-14.
9. Church MK, Bewley AP, Clough GF, Burrows LJ, Ferdinand SI, Petersen LJ. Studies into the mechanisms of dermal inflammation using cutaneous microdialysis. Int Arch Allergy Immunol. 1997;113(1-3):131-3.
10. Pesquero JB, Araujo RC, Heppenstall PA, Stucky CL, Silva JA Jr, Walther T, et al. Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc Natl Acad Sci USA. 2000;97(14):8140-5.
11. Cayla C, Todiras M, Iliescu R, Saul VV, Gross V, Pilz B, et al. Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension. FASEB J. 2007;21(8):1689-98.
12. Souza DG, Lomez ES, Pinho V, Pesquero JB, Bader M, Pesquero JL, et al. Role of bradykinin B2 and B1 receptors in the local, remote, and systemic inflammatory responses that follow intestinal ischemia and reperfusion injury. J Immunol. 2004;172(4):2542-8.
13. Klein J, Gonzalez J, Duchene J, Esposito L, Pradere JP, Neau E, et al. Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy. FASEB J. 2009;23(1):134-42.
14. Merino VF, Todiras M, Mori MA, Sales VM, Fonseca RG, Saul V, et al. Predisposition to atherosclerosis and aortic aneurysms in mice deficient in kinin B1 receptor and apolipoprotein E. J Mol Med (Berl). 2009;87(10):953-63.
15. Schulze-Topphoff U, Prat A, Prozorovski T, Siffrin V, Paterka M, Herz J, et al. Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system. Nat Med. 2009;15(7):788-93.
16. Raslan F, Schwarz T, Meuth SG, Austinat M, Bader M, Renne T, et al. Inhibition of bradykinin receptor B1 protects mice from focal brain injury by reducing blood-brain barrier leakage and inflammation. J Cereb Blood Flow Metab. 2010;30(8):1477-86.
17. Trabold R, Eros C, Zweckberger K, Relton J, Beck H, Nussberger J, et al. The role of bradykinin B(1) and B(2) receptors for secondary brain damage after traumatic brain injury in mice. J Cereb Blood Flow Metab. 2010;30(1):130-9.
18. Emanueli C, Bonaria Salis M, Stacca T, Pintus G, Kirchmair R, Isner JM, et al. Targeting kinin B(1) receptor for therapeutic neovascularization. Circulation. 2002;105(3):360-6.
19. Bader M. Kallikrein-kinin system in neovascularization. Arterioscler Thromb Vasc Biol. 2009;29(5):617-9.
20. Hillmeister P, Gatzke N, Dulsner A, Bader M, Schadock I, Hoefer I, et al. Arteriogenesis is modulated by bradykinin receptor signaling. Circ Res. 2011;109(5):524-33.
21. Mori MA, Araujo RC, Reis FC, Sgai DG, Fonseca RG, Barros CC, et al. Kinin B1 receptor deficiency leads to leptin hypersensitivity and resistance to obesity. Diabetes. 2008;57(6):1491-500.
22. Mori MA, Sales VM, Motta FL, Fonseca RG, Alenina N, Guadagnini D, et al. Kinin B1 receptor in adipocytes regulates glucose tolerance and predisposition to obesity. PLoS One. 2012;7(9):e44782.
23. Hojima Y, Cochrane CG, Wiggins RC, Austen KF, Stevens RL. In vitro activation of the contact (Hageman factor) system of plasma by heparin and chondroitin sulfate E. Blood. 1984;63(6):1453-9.
24. Oschatz C, Maas C, Lecher B, Jansen T, Bjorkqvist J, Tradler T, et al. Mast cells increase vascular permeability by heparin-initiated bradykinin formation in vivo. Immunity. 2011;34(2):258-68.
25. Renne T, Schmaier AH, Nickel KF, Blomback M, Maas C. In vivo roles of factor XII. Blood. 2012;120(22):4296-303.
26. Bork K, Fischer B, Dewald G. Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. Am J Med. 2003;114(4):294-8.
27. Bouillet L, Longhurst H, Boccon-Gibod I, Bork K, Bucher C, Bygum A, et al. Disease expression in women with hereditary angioedema. Am J Obstet Gynecol. 2008;199(5):e481-4.
28. Saule C, Boccon-Gibod I, Fain O, Kanny G, Plu-Bureau G, Martin L, et al. Benefits of progestin contraception in non-allergic angioedema. Clin Exp Allergy. 2013;43(4):475-82.
29. Rousset-Jablonski C, Thalabard JC, Gompel A. Tamoxifen contraindicated in women with hereditary angioedema? Ann Oncol. 2009;20(7):1281-2.
30. Jespersen J, Kluft C. Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen - levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivator. Thromb Haemost. 1985;54(2):454-9.
31. Farsetti A, Misiti S, Citarella F, Felici A, Andreoli M, Fantoni A, et al. Molecular basis of estrogen regulation of Hageman factor XII gene expression. Endocrinology. 1995;136(11):5076-83.
32. Madeddu P, Emanueli C, Song Q, Varoni MV, Demontis MP, Anania V, et al. Regulation of bradykinin B2-receptor expression by oestrogen. Br J Pharmacol. 1997;121(8):1763-9.
33. Ichikawa J, Sumino H, Ichikawa S, Ozaki M. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women. Am J Hypertens. 2006;19(7):744-9.
34. Lamontagne D, Konig A, Bassenge E, Busse R. Prostacyclin and nitric oxide contribute to the vasodilator action of acetylcholine and bradykinin in the intact rabbit coronary bed. J Cardiovasc Pharmacol. 1992;20(4):652-7.
35. O'Kane KP, Webb DJ, Collier JG, Vallance PJ. Local L-NG-monomethyl- arginine attenuates the vasodilator action of bradykinin in the human forearm. Br J Clin Pharmacol. 1994;38(4):311-5.
36. Duran WN, Breslin JW, Sanchez FA. The NO cascade, eNOS location, and microvascular permeability. Cardiovasc Res. 2010;87(2):254-61.